双鹭药业(002038) - 2016 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2016 was ¥258,842,648.45, a decrease of 6.66% compared to ¥277,303,455.96 in the same period last year[6] - Net profit attributable to shareholders was ¥149,095,308.53, down 16.75% from ¥179,088,812.64 year-on-year[6] - The net cash flow from operating activities decreased by 60.13%, from ¥166,821,451.54 to ¥66,509,966.95[6] - Basic and diluted earnings per share were both ¥0.22, a decline of 15.38% from ¥0.26 in the previous year[6] - Operating profit for the first half of 2016 is expected to range from 32,223.64 to 43,596.68 million yuan, reflecting a decrease of 15.00% to 15.00% compared to the same period in 2015[20] Assets and Shareholder Equity - Total assets increased by 3.95% to ¥3,910,081,479.56 from ¥3,761,619,252.45 at the end of the previous year[6] - Net assets attributable to shareholders rose by 4.05% to ¥3,722,882,711.39 from ¥3,577,847,732.32[6] - The weighted average return on equity decreased to 4.09% from 5.52%[6] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 35,791[10] - The largest shareholder, Xu Mingbo, holds 22.55% of the shares, while the second largest, Xinxiang Bailu Chemical Fiber Group Co., Ltd., holds 21.09%[10] Non-Recurring Items and Other Income - The company reported non-recurring gains of ¥4,236,415.37 during the reporting period[8] - Other income increased by 281.52% year-on-year, mainly due to an increase in government subsidies received[16] Changes in Assets and Expenses - Prepaid accounts increased by 44.31% compared to the beginning of the period, attributed to higher purchases of raw materials and service fees[16] - Other current assets surged by 334.18% compared to the beginning of the period, due to an increase in financial products[16] - Sales expenses rose by 53.77% year-on-year, primarily due to a change in product marketing strategy[16] - Financial expenses decreased by 93.44% year-on-year, mainly due to increased interest income from time deposits[16] - Asset impairment losses increased by 316.14% year-on-year, driven by an increase in accounts receivable and corresponding bad debt provisions[16] - Investment income decreased by 52.69% year-on-year, as the previous year included significant equity transfer transactions[16] Cash Flow and Investment Activities - The net cash flow from investment activities decreased by 2327.47% year-on-year, primarily due to increased cash payments for investments[17] - The net increase in cash and cash equivalents decreased by 343.63% year-on-year, also due to increased cash payments for investments[17]